BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:25AM EDT. Market open.
| Previous close | 4.5700 |
| Open | 4.6100 |
| Bid | 4.5100 x 100 |
| Ask | 4.5700 x 100 |
| Day's range | 4.5150 - 4.6800 |
| 52-week range | 4.0300 - 8.9600 |
| Volume | |
| Avg. volume | 3,269,659 |
| Market cap | 941.901M |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Heron Therapeutics (HRTX) Report Negative Earnings Next Week? What You Should Know
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to...
© 2024 Yahoo. All rights reserved.